Exicure, Inc. (XCUR)
1.29
-0.12
(-8.51%)
USD |
NASDAQ |
Aug 28, 16:00
1.295
0.00 (0.00%)
After-Hours: 20:00
Exicure Cash from Operations (Quarterly) : -0.887M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.887M |
| March 31, 2026 | -1.142M |
| December 31, 2025 | -1.147M |
| September 30, 2025 | -3.528M |
| June 30, 2025 | -2.282M |
| March 31, 2025 | -1.598M |
| December 31, 2024 | -0.845M |
| September 30, 2024 | -0.449M |
| June 30, 2024 | -1.166M |
| March 31, 2024 | -0.45M |
| December 31, 2023 | -0.816M |
| September 30, 2023 | -1.412M |
| June 30, 2023 | -4.811M |
| March 31, 2023 | -3.318M |
| December 31, 2022 | -7.276M |
| September 30, 2022 | -6.548M |
| June 30, 2022 | -9.078M |
| March 31, 2022 | -13.26M |
| Date | Value |
|---|---|
| December 31, 2021 | -13.80M |
| September 30, 2021 | 4.863M |
| June 30, 2021 | -11.08M |
| March 31, 2021 | -14.81M |
| December 31, 2020 | -11.81M |
| September 30, 2020 | -8.549M |
| June 30, 2020 | -11.07M |
| March 31, 2020 | -7.847M |
| December 31, 2019 | 15.33M |
| September 30, 2019 | -4.965M |
| June 30, 2019 | -5.036M |
| March 31, 2019 | -4.012M |
| December 31, 2018 | -5.963M |
| September 30, 2018 | -4.193M |
| June 30, 2018 | -4.684M |
| March 31, 2018 | -4.647M |
| December 31, 2017 | -5.342M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -14.15M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | -19.83M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | -5.103M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -6.385M |
| Free Cash Flow Per Share (Quarterly) | -0.1392 |
| Free Cash Flow to Equity (Quarterly) | -0.865M |
| Free Cash Flow to Firm (Quarterly) | -0.887M |
| Free Cash Flow Yield | -77.81% |